Source:http://linkedlifedata.com/resource/pubmed/id/16426921
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-23
|
pubmed:abstractText |
The proto-oncogene c-KIT (CD117) is highly expressed in normal breast epithelium and is decreased in invasive breast cancer. In this study, we analyzed the protein expression and the mutational status of c-KIT in ductal carcinoma in situ (DCIS) of the breast and correlated these findings with nuclear grade, architectural pattern, and expression of HER-2, estrogen receptor (ER)-alpha, and progesterone receptor (PR). C-KIT, HER-2, ER, and PR expression were analyzed immunohistochemically in 106 cases of paraffin-embedded DCIS (85 pure DCIS and 21 DCIS with concurrent carcinoma). Direct sequencing of exons 9 and 11 of the c-KIT gene was performed to analyze the hot spot mutational regions in representative cases. C-KIT expression was found in 55 (52.8%) of all DCIS, correlating with high nuclear grade (P < .0001), comedonecrosis (P < .0001), and solid growth pattern (P = .001). Furthermore, c-KIT expression was strongly associated with HER-2 positivity (P < .0001) and was significantly lower in ER- or PR-positive cases (P = .001 and P = .006, respectively). C-KIT expression alone or co-expression with HER-2 in pure DCIS did not differ significantly from DCIS with invasive component (P = .09). Mutational analysis in 6 c-KIT-positive DCIS revealed no activating mutations in exons 9 or 11. Our findings suggest that the expression of c-KIT protein might define a subset of poorly differentiated, HER-2-positive DCIS with decreased expression of steroid hormone receptors, comedonecrosis, and a solid growth pattern. The implications of c-KIT and HER-2 co-expression for breast carcinogenesis should be further evaluated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0046-8177
|
pubmed:author |
pubmed-author:DialloRaihanatouR,
pubmed-author:EngelsKnutK,
pubmed-author:GabbertHelmut EHE,
pubmed-author:GeddertHeleneH,
pubmed-author:JackischChristianC,
pubmed-author:KarnThomasT,
pubmed-author:KaufmannManfredM,
pubmed-author:KisslerStefanS,
pubmed-author:PorembaChristopherC,
pubmed-author:RodyAchimA,
pubmed-author:SchaeferKarl-LudwigKL,
pubmed-author:ShroyerKenneth RKR,
pubmed-author:TingEvelynE
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-11
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16426921-Adolescent,
pubmed-meshheading:16426921-Adult,
pubmed-meshheading:16426921-Aged,
pubmed-meshheading:16426921-Aged, 80 and over,
pubmed-meshheading:16426921-Breast Neoplasms,
pubmed-meshheading:16426921-Carcinoma, Intraductal, Noninfiltrating,
pubmed-meshheading:16426921-Female,
pubmed-meshheading:16426921-Humans,
pubmed-meshheading:16426921-In Situ Hybridization, Fluorescence,
pubmed-meshheading:16426921-Middle Aged,
pubmed-meshheading:16426921-Neoplasm Invasiveness,
pubmed-meshheading:16426921-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:16426921-Receptor, erbB-2,
pubmed-meshheading:16426921-Receptors, Estrogen,
pubmed-meshheading:16426921-Receptors, Progesterone
|
pubmed:year |
2006
|
pubmed:articleTitle |
C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
|
pubmed:affiliation |
Institute of Pathology, Heinrich-Heine-University of Düsseldorf, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|